The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Regimen Utilizing Neratinib For Breast Cancer - EP3000467

The patent EP3000467 was granted to Wyeth on Mar 1, 2023. The application was filed on Mar 24, 2010 under application number EP15188350A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3000467

WYETH
Application Number
EP15188350A
Filing Date
Mar 24, 2010
Status
Granted And Under Opposition
Jan 27, 2023
Publication Date
Mar 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKDec 1, 2023ELKINGTON AND FIFEADMISSIBLE
ALFRED E TIEFENBACHERNov 28, 2023HAMM & WITTKOPPADMISSIBLE
HEXALNov 3, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005059678
DESCRIPTIONUS2007104721
DESCRIPTIONUS6002008
DESCRIPTIONUS6288082
DESCRIPTIONUS6297258
DESCRIPTIONUS6387371
DESCRIPTIONUS6399063
DESCRIPTIONUS6821515
DESCRIPTIONWO9633978
DESCRIPTIONWO9633980
OPPOSITIONWO2007056118
SEARCHWO2007056118

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents